<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36700308</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1738-1088</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology</Title><ISOAbbreviation>Clin Psychopharmacol Neurosci</ISOAbbreviation></Journal><ArticleTitle>The Clinical Observation of Inflammation Theory for Depression: The Initiative of the Formosa Long COVID Multicenter Study (FOCuS).</ArticleTitle><Pagination><StartPage>10</StartPage><EndPage>18</EndPage><MedlinePgn>10-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.9758/cpn.2023.21.1.10</ELocationID><Abstract><AbstractText>There is growing evidence that the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with increased risks of psychiatric sequelae. Depression, anxiety, cognitive impairments, sleep disturbance, and fatigue during and after the acute phase of COVID-19 are prevalent, long-lasting, and exerting negative consequences on well-being and imposing a huge burden on healthcare systems and society. This current review presented timely updates of clinical research findings, particularly focusing on the pathogenetic mechanisms underlying the neuropsychiatric sequelae, and identified potential key targets for developing effective treatment strategies for long COVID. In addition, we introduced the Formosa Long COVID Multicenter Study (FOCuS), which aims to apply the inflammation theory to the pathogenesis and the psychosocial and nutrition treatments of post-COVID depression and anxiety.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shu-Tsen</ForeName><Initials>ST</Initials><Identifier Source="ORCID">0000-0001-7924-9025</Identifier><AffiliationInfo><Affiliation>Division of Child and Adolescent Psychiatry &amp; Division of Developmental and Behavioral Pediatrics, China Medical University Children's Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Sheng-Che</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0003-0846-9789</Identifier><AffiliationInfo><Affiliation>An-Nan Hospital, China Medical University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Jane Pei-Chen</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0001-5582-0928</Identifier><AffiliationInfo><Affiliation>Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Child Psychiatry, Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kai-Jie</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0002-3964-9339</Identifier><AffiliationInfo><Affiliation>Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Che-Sheng</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0002-6911-1839</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Chia-Chun</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0001-7034-3736</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Taoyuan Psychiatric Center, Taoyuan City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Chih-Sung</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0003-1138-5586</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Ching-Fang</ForeName><Initials>CF</Initials><Identifier Source="ORCID">0000-0001-5146-4575</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Medicine, Virginia Tech Carilion Clinic School of Medicine, Roanoke, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shao-Cheng</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-7009-5338</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satyanarayanan</LastName><ForeName>Senthil Kumaran</ForeName><Initials>SK</Initials><Identifier Source="ORCID">0000-0002-0513-4943</Identifier><AffiliationInfo><Affiliation>Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Kuan-Pin</ForeName><Initials>KP</Initials><Identifier Source="ORCID">0000-0002-4501-2502</Identifier><AffiliationInfo><Affiliation>An-Nan Hospital, China Medical University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Clin Psychopharmacol Neurosci</MedlineTA><NlmUniqueID>101207332</NlmUniqueID><ISSNLinking>1738-1088</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Neuropsychiatric sequelae</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome</Keyword></KeywordList><CoiStatement>
<b>Conflicts of Interest</b>
. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>26</Day><Hour>3</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36700308</ArticleId><ArticleId IdType="pmc">PMC9889898</ArticleId><ArticleId IdType="doi">10.9758/cpn.2023.21.1.10</ArticleId><ArticleId IdType="pii">cpn.2023.21.1.10</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sivan M, Taylor S. NICE guideline on long covid. BMJ. 2020;371:m4938. doi: 10.1136/bmj.m4938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi con-sensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022;322:C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid- mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648. Erratum in: BMJ 2021;374:n1944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang CS, Ga&#x142;ecki P, Su KP. Unresolved systemic inflam-mation, long COVID, and the common pathomechanisms of somatic and psychiatric comorbidity. J Clin Med. 2022;11:5114. doi: 10.3390/jcm11175114.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11175114</ArticleId><ArticleId IdType="pmc">PMC9457285</ArticleId><ArticleId IdType="pubmed">36079040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long- COVID and how should we manage it? Lung. 2021;199:113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022;74:1191&#x2013;1198. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, et al.  A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv. 22275532 [Online] 2022.  [cited 2022 Sep 4].  
https://doi.org/10.1101/2022.05.26.22275532. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.26.22275532</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Fugledalen L, Jespersen AE, Sattler SM, Podlekareva D, Rungby J, et al. Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: pattern, severity, and functional implications. Eur Neuropsychopharmacol. 2022;59:82&#x2013;92. doi: 10.1016/j.euroneuro.2022.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2022.04.004</ArticleId><ArticleId IdType="pmc">PMC9008126</ArticleId><ArticleId IdType="pubmed">35561540</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeles MR, Wanni Arachchige Dona S, Nguyen HD, Le LK, Hensher M. Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan. BMC Public Health. 2022;22:757. doi: 10.1186/s12889-022-13169-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-13169-x</ArticleId><ArticleId IdType="pmc">PMC9009167</ArticleId><ArticleId IdType="pubmed">35421963</ArticleId></ArticleIdList></Reference><Reference><Citation>Solmi M, Estrad&#xe9; A, Thompson T, Agorastos A, Radua J, Cortese S, et al. Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times- Children and Adolescents (COH-FIT-C&amp;A) J Affect Disord. 2022;299:367&#x2013;376. doi: 10.1016/j.jad.2021.09.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.09.090</ArticleId><ArticleId IdType="pmc">PMC8486586</ArticleId><ArticleId IdType="pubmed">34606810</ArticleId></ArticleIdList></Reference><Reference><Citation>Solmi M, Estrad&#xe9; A, Thompson T, Agorastos A, Radua J, Cortese S, et al. The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT- Adults): design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic. J Affect Disord. 2022;299:393&#x2013;407. doi: 10.1016/j.jad.2021.07.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.07.048</ArticleId><ArticleId IdType="pmc">PMC8288233</ArticleId><ArticleId IdType="pubmed">34949568</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderlind WM, Rabinovitz BB, Miao IY, Oberlin LE, Bueno- Castellano C, Fridman C, et al. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. Curr Opin Psychiatry. 2021;34:420&#x2013;433. doi: 10.1097/YCO.0000000000000713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YCO.0000000000000713</ArticleId><ArticleId IdType="pmc">PMC8183238</ArticleId><ArticleId IdType="pubmed">34016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar- Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Llach CD, Vieta E. Mind long COVID: psychiatric sequelae of SARS-CoV-2 infection. Eur Neuropsychopharmacol. 2021;49:119&#x2013;121. doi: 10.1016/j.euroneuro.2021.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.04.019</ArticleId><ArticleId IdType="pmc">PMC8098059</ArticleId><ArticleId IdType="pubmed">33992951</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourmistrova NW, Solomon T, Braude P, Strawbridge R, Carter B. Long-term effects of COVID-19 on mental health: a systematic review. J Affect Disord. 2022;299:118&#x2013;125. doi: 10.1016/j.jad.2021.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.11.031</ArticleId><ArticleId IdType="pmc">PMC8758130</ArticleId><ArticleId IdType="pubmed">34798148</ArticleId></ArticleIdList></Reference><Reference><Citation>Khraisat B, Toubasi A, AlZoubi L, Al-Sayegh T, Mansour A. Meta-analysis of prevalence: the psychological sequelae among COVID-19 survivors. Int J Psychiatry Clin Pract. 2022;26:234&#x2013;243. doi: 10.1080/13651501.2021.1993924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13651501.2021.1993924</ArticleId><ArticleId IdType="pubmed">34709105</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID- 19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36:681&#x2013;702. doi: 10.1007/s40263-022-00931-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Mental Disorders Collaborators, author. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398:1700&#x2013;1712. doi: 10.1016/s0140-6736(21)02143-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(21)02143-7</ArticleId><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancourt D, Steptoe A, Bu F. Long-term psychological consequences of long COVID: a propensity score matching analysis comparing trajectories of depression and anxiety symptoms before and after contracting long COVID vs short COVID. medRxiv. 22273305 [Online] 2022.  [cited 2022 Sep 4].  
https://doi.org/10.1101/2022.04.01.22273305. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.04.01.22273305</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SU, Amundsen OM, Johnson MS, Hoffart A, Hals&#xf8;y &#xd8;, Skjerdingstad N, et al. Psychiatric symptoms in COVID- 19-positive individuals in the general population: trajectories of depression, anxiety, and insomnia. Psychiatry Res. 2022;317:114806. doi: 10.1016/j.psychres.2022.114806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114806</ArticleId><ArticleId IdType="pmc">PMC9392896</ArticleId><ArticleId IdType="pubmed">36084543</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber J, Prinstein MJ, Clark LA, Rottenberg J, Abramowitz JS, Albano AM, et al. Mental health and clinical psychological science in the time of COVID-19: challenges, opportunities, and a call to action. Am Psychol. 2021;76:409&#x2013;426. doi: 10.1037/amp0000707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/amp0000707</ArticleId><ArticleId IdType="pmc">PMC7873160</ArticleId><ArticleId IdType="pubmed">32772538</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhanom Ghebreyesus T. Addressing mental health needs: an integral part of COVID-19 response. World Psychiatry. 2020;19:129&#x2013;130. doi: 10.1002/wps.20768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20768</ArticleId><ArticleId IdType="pmc">PMC7214944</ArticleId><ArticleId IdType="pubmed">32394569</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62&#x2008;354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130&#x2013;140. doi: 10.1016/S2215-0366(20)30462-4. Erratum in: Lancet Psychiatry 2021;8:e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SW, Su KP. Using psychoneuroimmunity against COVID-19. Brain Behav Immun. 2020;87:4&#x2013;5. doi: 10.1016/j.bbi.2020.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.025</ArticleId><ArticleId IdType="pmc">PMC7194899</ArticleId><ArticleId IdType="pubmed">32234338</ArticleId></ArticleIdList></Reference><Reference><Citation>Bli&#x17a;niewska-Kowalska KM, Halaris A, Wang SC, Su KP, Maes M, Berk M, et al. A review of the global impact of the COVID-19 pandemic on public mental health, with a comparison between the USA, Australia, and Poland with Taiwan and Thailand. Med Sci Monit. 2021;27:e932220. doi: 10.12659/MSM.932220.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.932220</ArticleId><ArticleId IdType="pmc">PMC8122850</ArticleId><ArticleId IdType="pubmed">33972496</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Villa G, De Lorenzo R, Rovere Querini P, Benedetti F. Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue. J Psychiatr Res. 2022;155:112&#x2013;119. doi: 10.1016/j.jpsychires.2022.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.08.008</ArticleId><ArticleId IdType="pmc">PMC9391361</ArticleId><ArticleId IdType="pubmed">36029623</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottemanne H, Gouraud C, Hulot JS, Blanchard A, Ranque B, Lahlou-Lafor&#xea;t K, et al. Do anxiety and depression predict persistent physical symptoms after a severe COVID-19 episode? A prospective study. Front Psychiatry. 2021;12:757685. doi: 10.3389/fpsyt.2021.757685.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.757685</ArticleId><ArticleId IdType="pmc">PMC8631493</ArticleId><ArticleId IdType="pubmed">34858230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. Persistent psychopathology and neurocog-nitive impairment in COVID-19 survivors: effect of inflam-matory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138&#x2013;147. doi: 10.1016/j.bbi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CH, Giuliani F. The role of inflammation in depression and fatigue. Front Immunol. 2019;10:1696. doi: 10.3389/fimmu.2019.01696.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01696</ArticleId><ArticleId IdType="pmc">PMC6658985</ArticleId><ArticleId IdType="pubmed">31379879</ArticleId></ArticleIdList></Reference><Reference><Citation>Semyachkina-Glushkovskaya O, Mamedova A, Vinnik V, Klimova M, Saranceva E, Ageev V, et al. Brain mechanisms of COVID-19-sleep disorders. Int J Mol Sci. 2021;22:6917. doi: 10.3390/ijms22136917.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22136917</ArticleId><ArticleId IdType="pmc">PMC8268116</ArticleId><ArticleId IdType="pubmed">34203143</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiatry. 2021;78:682&#x2013;683. doi: 10.1001/jamapsychiatry.2021.0500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0500</ArticleId><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CP, Chang CM, Yang CC, Pariante CM, Su KP. Long COVID and long chain fatty acids (LCFAs): psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19. Brain Behav Immun. 2022;103:19&#x2013;27. doi: 10.1016/j.bbi.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC8977215</ArticleId><ArticleId IdType="pubmed">35390469</ArticleId></ArticleIdList></Reference><Reference><Citation>Han QQ, Yu J. Inflammation: a mechanism of depression? Neurosci Bull. 2014;30:515&#x2013;523. doi: 10.1007/s12264-013-1439-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-013-1439-3</ArticleId><ArticleId IdType="pmc">PMC5562613</ArticleId><ArticleId IdType="pubmed">24838302</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22&#x2013;34. doi: 10.1038/nri.2015.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2015.5</ArticleId><ArticleId IdType="pmc">PMC5542678</ArticleId><ArticleId IdType="pubmed">26711676</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107:234&#x2013;256. doi: 10.1016/j.neuron.2020.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.06.002</ArticleId><ArticleId IdType="pmc">PMC7381373</ArticleId><ArticleId IdType="pubmed">32553197</ArticleId></ArticleIdList></Reference><Reference><Citation>Milaneschi Y, Kappelmann N, Ye Z, Lamers F, Moser S, Jones PB, et al. Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts. Mol Psychiatry. 2021;26:7393&#x2013;7402. doi: 10.1038/s41380-021-01188-w. Erratum in: Mol Psychiatry 2022;27:1856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01188-w</ArticleId><ArticleId IdType="pmc">PMC8873022</ArticleId><ArticleId IdType="pubmed">34135474</ArticleId></ArticleIdList></Reference><Reference><Citation>Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med. 2019;49:1958&#x2013;1970. doi: 10.1017/S0033291719001454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291719001454</ArticleId><ArticleId IdType="pmc">PMC6712955</ArticleId><ArticleId IdType="pubmed">31258105</ArticleId></ArticleIdList></Reference><Reference><Citation>Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD. Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav Immun. 2020;87:901&#x2013;909. doi: 10.1016/j.bbi.2020.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.02.010</ArticleId><ArticleId IdType="pmc">PMC7327519</ArticleId><ArticleId IdType="pubmed">32113908</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46&#x2013;56. doi: 10.1038/nrn2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2297</ArticleId><ArticleId IdType="pmc">PMC2919277</ArticleId><ArticleId IdType="pubmed">18073775</ArticleId></ArticleIdList></Reference><Reference><Citation>Dooley LN, Kuhlman KR, Robles TF, Eisenberger NI, Craske MG, Bower JE. The role of inflammation in core features of depression: insights from paradigms using exogenously-induced inflammation. Neurosci Biobehav Rev. 2018;94:219&#x2013;237. doi: 10.1016/j.neubiorev.2018.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2018.09.006</ArticleId><ArticleId IdType="pmc">PMC6192535</ArticleId><ArticleId IdType="pubmed">30201219</ArticleId></ArticleIdList></Reference><Reference><Citation>Gritti D, Delvecchio G, Ferro A, Bressi C, Brambilla P. Neuro-inflammation in major depressive disorder: a review of PET imaging studies examining the 18-kDa translocator protein. J Affect Disord. 2021;292:642&#x2013;651. doi: 10.1016/j.jad.2021.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.06.001</ArticleId><ArticleId IdType="pubmed">34153835</ArticleId></ArticleIdList></Reference><Reference><Citation>Nettis MA, Pariante CM. Is there neuroinflammation in depression? Understanding the link between the brain and the peripheral immune system in depression. Int Rev Neurobiol. 2020;152:23&#x2013;40. doi: 10.1016/bs.irn.2019.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2019.12.004</ArticleId><ArticleId IdType="pubmed">32450998</ArticleId></ArticleIdList></Reference><Reference><Citation>Green C, Shen X, Stevenson AJ, Conole ELS, Harris MA, Barbu MC, et al. Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorder. Brain Behav Immun. 2021;92:39&#x2013;48. doi: 10.1016/j.bbi.2020.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.11.024</ArticleId><ArticleId IdType="pmc">PMC7910280</ArticleId><ArticleId IdType="pubmed">33221487</ArticleId></ArticleIdList></Reference><Reference><Citation>Hidese S, Hattori K, Sasayama D, Tsumagari T, Miyakawa T, Matsumura R, et al. Cerebrospinal fluid inflammatory cytokine levels in patients with major psychiatric disorders: a multiplex immunoassay study. Front Pharmacol. 2021;11:594394. doi: 10.3389/fphar.2020.594394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.594394</ArticleId><ArticleId IdType="pmc">PMC7941212</ArticleId><ArticleId IdType="pubmed">33708113</ArticleId></ArticleIdList></Reference><Reference><Citation>Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25&#x2013;32. doi: 10.1016/j.cytogfr.2020.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.05.003</ArticleId><ArticleId IdType="pmc">PMC7211650</ArticleId><ArticleId IdType="pubmed">32446778</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020;55:105954. doi: 10.1016/j.ijantimicag.2020.105954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105954</ArticleId><ArticleId IdType="pmc">PMC7118634</ArticleId><ArticleId IdType="pubmed">32234467</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo L, et al.  Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP) medRxiv. 20021832 [Online] 2020.  [cited 2022 Sep 4].  
https://doi.org/10.1101/2020.02.10.20021832. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.10.20021832</ArticleId></ArticleIdList></Reference><Reference><Citation>Viszlayov&#xe1; D, Sojka M, Dobrodenkov&#xe1; S, Szab&#xf3; S, Bilec O, Turzov&#xe1; M, et al. SARS-CoV-2 RNA in the cerebrospinal fluid of a patient with long COVID. Ther Adv Infect Dis. 2021;8:20499361211048572. doi: 10.1177/20499361211048572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211048572</ArticleId><ArticleId IdType="pmc">PMC8511908</ArticleId><ArticleId IdType="pubmed">34659752</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodagar A, Javed R, Tahir H, Razak SIA, Shakir M, Naeem M, et al. Pathological features and neuroinflammatory mechanisms of SARS-CoV-2 in the brain and potential therapeutic approaches. Biomolecules. 2022;12:971. doi: 10.3390/biom12070971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12070971</ArticleId><ArticleId IdType="pmc">PMC9313047</ArticleId><ArticleId IdType="pubmed">35883527</ArticleId></ArticleIdList></Reference><Reference><Citation>Pariante CM. Increased inflammation in depression: a little in all, or a lot in a few? Am J Psychiatry. 2021;178:1077&#x2013;1079. doi: 10.1176/appi.ajp.2021.21101043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2021.21101043</ArticleId><ArticleId IdType="pubmed">34855454</ArticleId></ArticleIdList></Reference><Reference><Citation>Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140:774&#x2013;815. doi: 10.1037/a0035302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0035302</ArticleId><ArticleId IdType="pmc">PMC4006295</ArticleId><ArticleId IdType="pubmed">24417575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SC, Su KP, Pariante CM. The three frontlines against COVID-19: brain, behavior, and immunity. Brain Behav Immun. 2021;93:409&#x2013;414. doi: 10.1016/j.bbi.2021.01.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.01.030</ArticleId><ArticleId IdType="pmc">PMC7857976</ArticleId><ArticleId IdType="pubmed">33548496</ArticleId></ArticleIdList></Reference><Reference><Citation>Shields GS, Spahr CM, Slavich GM. Psychosocial interventions and immune system function: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry. 2020;77:1031&#x2013;1043. doi: 10.1001/jamapsychiatry.2020.0431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2020.0431</ArticleId><ArticleId IdType="pmc">PMC7272116</ArticleId><ArticleId IdType="pubmed">32492090</ArticleId></ArticleIdList></Reference><Reference><Citation>Black DS, Slavich GM. Mindfulness meditation and the immune system: a systematic review of randomized controlled trials. Ann N Y Acad Sci. 2016;1373:13&#x2013;24. doi: 10.1111/nyas.12998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.12998</ArticleId><ArticleId IdType="pmc">PMC4940234</ArticleId><ArticleId IdType="pubmed">26799456</ArticleId></ArticleIdList></Reference><Reference><Citation>Bower JE, Irwin MR. Mind-body therapies and control of inflammatory biology: a descriptive review. Brain Behav Immun. 2016;51:1&#x2013;11. doi: 10.1016/j.bbi.2015.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.06.012</ArticleId><ArticleId IdType="pmc">PMC4679419</ArticleId><ArticleId IdType="pubmed">26116436</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan N, Irwin MR, Chung M, Wang C. The effects of mind-body therapies on the immune system: meta-analysis. PLoS One. 2014;9:e100903. doi: 10.1371/journal.pone.0100903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0100903</ArticleId><ArticleId IdType="pmc">PMC4079606</ArticleId><ArticleId IdType="pubmed">24988414</ArticleId></ArticleIdList></Reference><Reference><Citation>Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, et al. International Society for Nutritional Psy-chiatry Research practice guidelines for Omega-3 fatty acids in the treatment of major depressive disorder. Psychother Psychosom. 2019;88:263&#x2013;273. doi: 10.1159/000502652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000502652</ArticleId><ArticleId IdType="pubmed">31480057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68:1056&#x2013;1061. doi: 10.4088/JCP.v68n0712.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.v68n0712</ArticleId><ArticleId IdType="pubmed">17685742</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi D, Su KP, Usuda K, Pei-Chen Chang J, Chiang YJ, Chen HT, et al. The efficacy of Omega-3 fatty acids for depressive symptoms among pregnant women in Japan and Taiwan: a randomized, double-blind, placebo-controlled trial (SYNCHRO; NCT01948596) Psychother Psychosom. 2019;88:122&#x2013;124. doi: 10.1159/000495296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000495296</ArticleId><ArticleId IdType="pubmed">30540990</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu CC, Huang SY, Su KP. Omega-3 polyunsaturated fatty acids for postpartum depression. Am J Obstet Gynecol. 2004;190:582&#x2013;583.:author reply 583. doi: 10.1016/j.ajog.2003.10.705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2003.10.705</ArticleId><ArticleId IdType="pubmed">15002412</ArticleId></ArticleIdList></Reference><Reference><Citation>Su KP, Tseng PT, Lin PY, Okubo R, Chen TY, Chen YW, et al. Association of use of Omega-3 polyunsaturated fatty acids with changes in severity of anxiety symptoms: a systematic review and meta-analysis. JAMA Netw Open. 2018;1:e182327. doi: 10.1001/jamanetworkopen.2018.2327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2018.2327</ArticleId><ArticleId IdType="pmc">PMC6324500</ArticleId><ArticleId IdType="pubmed">30646157</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JP, Pariante CM, Su KP. Omega-3 fatty acids in the psychological and physiological resilience against COVID-19. Prostaglandins Leukot Essent Fatty Acids. 2020;161:102177. doi: 10.1016/j.plefa.2020.102177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plefa.2020.102177</ArticleId><ArticleId IdType="pmc">PMC7516470</ArticleId><ArticleId IdType="pubmed">33031994</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabbir MA, Mehak F, Khan ZM, Ahmed W, Haq SMAU, Khan MR, et al. Delving the role of nutritional psychiatry to mitigate the COVID-19 pandemic induced stress, anxiety and depression. Trends Food Sci Technol. 2022;120:25&#x2013;35. doi: 10.1016/j.tifs.2021.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tifs.2021.12.035</ArticleId><ArticleId IdType="pmc">PMC8720048</ArticleId><ArticleId IdType="pubmed">35002078</ArticleId></ArticleIdList></Reference><Reference><Citation>Iddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR, et al. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID- 19 crisis. Nutrients. 2020;12:1562. doi: 10.3390/nu12061562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061562</ArticleId><ArticleId IdType="pmc">PMC7352291</ArticleId><ArticleId IdType="pubmed">32471251</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B, Eshaghian E, Chuang J, Covasa M. Do diet and dietary supplements mitigate clinical outcomes in COVID-19? Nutrients. 2022;14:1909. doi: 10.3390/nu14091909.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14091909</ArticleId><ArticleId IdType="pmc">PMC9104892</ArticleId><ArticleId IdType="pubmed">35565876</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>